Dexmedetomidine as Adjuvant in Scalp Nerve Block for Craniotomy: A Double-Blind Randomized Clinical Trial
DOI:
https://doi.org/10.24843/q23wyc88Keywords:
Craniotomy, Dexmedetomidine, Hemodynamic Stability, Inflamation, Postoperative pain, Scalp BlockAbstract
Introduction: Scalp nerve block (SNB) is an effective adjunct for attenuating hemodynamic responses and reducing postoperative pain in craniotomy. Dexmedetomidine (DEX), with its analgesic and anti-inflammatory properties, may enhance the quality of SNB. This study evaluated the effects of adding DEX to SNB on hemodynamic stability, postoperative pain, inflammatory response, and analgesic duration in craniotomy patients.
Methods: A double-blind, parallel-group randomized clinical trial was conducted on 36 adult patients undergoing elective craniotomy (July–September 2025) at a tertiary hospital Denpasar. Participants received SNB using 0.375% ropivacaine (20 mL) with or without DEX 1 µg/kg under standardized general anesthesia. Outcomes included mean arterial pressure (MAP), Visual Analog Scale (VAS) scores at 12 and 24 hours, neutrophil-to-lymphocyte ratio (ΔNLR), and time to first rescue analgesic (TTFAR). Statistical analyses used mixed ANOVA and Mann–Whitney U tests. Ethical approval number was 2159/UN14.2.2.VII.14/LT/2025.
Results: MAP was significantly lower in the DEX group at 10 minutes (Δ = 4.89 mmHg; 95% CI 1.62–8.16), 20 minutes (Δ = 4.83; 95% CI 1.57–8.10), 30 minutes (Δ = 3.67; 95% CI 0.40–6.94), and upon PACU arrival (Δ = 3.72; 95% CI 0.45–6.99) (all p < 0.05). Median VAS scores were significantly lower with DEX at 12 hours (1.50 vs 3.00; p < 0.001) and 24 hours (1.00 vs 2.00; p < 0.001). ΔNLR was reduced in the DEX group (−0.56 vs 3.08; p = 0.004). TTFAR was markedly prolonged (554 vs 257 minutes; p < 0.001). No adverse events were reported.
Conclusion: Dexmedetomidine added to scalp nerve block enhances hemodynamic stability, reduces postoperative pain for up to 24 hours, suppresses early systemic inflammation, and prolongs analgesic duration in craniotomy without observed complications. DEX–SNB represents a beneficial component of multimodal analgesia in neuroanesthesia and may support enhanced recovery pathways
Downloads
References
1. Yang Y, Ou M, Zhou H, Tan L, Hu Y, Li Y, et al. Effect of Scalp Nerve Block with Ropivacaine on Postoperative Pain in Patients Undergoing Craniotomy: A Randomized, Double Blinded Study. Sci Rep. 2020 Feb 13;10(1):2529.
2. Pratama RA, Laksono BH, Fatoni AZ. Manajemen Nyeri Akut Pasca-Kraniotomi. J Anaesth Pain. 2020 Oct 31;1(3):28–38.
3. Carella M, Tran G, Bonhomme VL, Franssen C. Influence of Levobupivacaine Regional Scalp Block on Hemodynamic Stability, Intra- and Postoperative Opioid Consumption in Supratentorial Craniotomies: A Randomized Controlled Trial. Anesth Analg. 2021 Feb;132(2):500–11.
4. Wang Q, Feng L. Evaluation of dexmedetomidine as an adjuvant to low-concentration lidocaine/ropivacaine mixtures in ultrasound-guided axillary brachial plexus block. BMC Anesthesiol. 2025 July 17;25(1):347.
5. Praisontarangkul V, Saringcarinkul A, Pin-on P, et al. Effect of Adding Dexmedetomidine to 0.5% Bupivacaine on Scalp Block on Intraoperative Hemodynamics During the First Hour of Surgery and Anesthetic Requirement in Intracranial Surgery. Biomed Sci Clin Med. 2024 Oct 1;63(4):242–50.
6. Wang K, Wu M, Xu J, Wu C, Zhang B, Wang G, et al. Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis. Br J Anaesth. 2019 Dec;123(6):777–94.
7. Bai L, Zhao L, Jia F, Liu Y, Li P. Effects of dexmedetomidine-ropivacaine assisted combined spinal-epidural anesthesia on neutrophil-lymphocyte ratio and postoperative delirium in elderly patients with intertrochanteric femoral fracture. Front Pharmacol. 2025 Jan 30;15:1454452.
8. Sahana BN, Sri Devi R, Samantaray A, Hemanth N, Pasupuleti H, Mangu HR. Comparison of effects of dexmedetomidine added to ropivacaine versus ropivacaine alone infiltration scalp block for attenuation of the haemodynamic response to skull pin placement in neurosurgical procedures: A double-blind, randomised clinical trial. Indian J Anaesth. 2021 Nov;65(11):782–8.
9. Stachtari C, Stergiouda Z, Koraki E, Sifaki F, Bagntasarian S, Chatzopoulos S. Dexmedetomidine as an adjuvant to scalp block in patients undergoing elective craniotomy: A prospective randomized controlled trial. Clin Neurol Neurosurg. 2023 Apr;227:107669.
10. Chen Z, Liu Z, Feng C, Jin Y, Zhao X. Dexmedetomidine as an Adjuvant in Peripheral Nerve Block. Drug Des Devel Ther. 2023 May;Volume 17:1463–84.
11. Chen Y, Du L, Wang L, Shi Y, Liao M, Zhong M, et al. Effects of Dexmedetomidine on Systemic Inflammation and Postoperative Complications in Laparoscopic Pancreaticoduodenectomy: A Double‐blind Randomized Controlled Trial. World J Surg. 2023 Feb;47(2):500–9.
12. Peršec J, Šribar A, Ilić M, Mamić I, Kifer D, Domijan AM, et al. Effects of epidurally administered dexmedetomidine and dexamethasone on postoperative pain, analgesic requirements, inflammation, and oxidative stress in thoracic surgery. Acta Pharm. 2023 Dec 1;73(4):691–708.
Downloads
Published
Data Availability Statement
All datasets generated and/or analysed for this study are available from the corresponding author upon reasonable request.
Issue
Section
License
Copyright (c) 2025 Putu Eka Nantha Kusuma, I Putu Pramana Suarjaya, Pontisomaya Parami, IGAG Utara Hartawan, I Gusti Ngurah Mahaalit Aribawa, I Putu Kurniyanta, Ida Bagus Krisna Jaya Sutawan, Putu Herdita Sudiantara, I Made Gede Widnyana, Tjokorda Gde Agung Senapathi (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share, use, distribute, and reproduce the work in any medium, provided the original author and source are properly credited.
